Article
Glycophorin A mutations and risk of secondary leukaemia in patients treated for childhood acute lymphoblastic leukaemia.
British journal of haematology - 1 Apr 1996
Boyse J, Hewitt M, Mott M G
Abstract excerpt
Survivors of child acute lymphoblastic leukaemia (ALL) have a higher than expected risk of developing secondary acute myeloid leukaemia (AML). The glycophorin A (GPA) mutation assay measures the frequency of variant NO and NN erythrocytes in MN heterozygotes. A raised variant frequency (Vf) has been shown in patients treated with chemotherapy known to be at risk of secondary leukaemia. ALL patients were...
Topics
- Acute Disease
- Child
- Child, Preschool
- Female
- Genetic Markers
- Genetic Techniques
- Glycophorins
- Humans
- Leukemia, Myeloid
- Male
- Mutation
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
